Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Ann Oncol ; 22(1): 118-126, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20603436

RESUMO

BACKGROUND: the interplay between comorbidity, age and performance status (PS) as predictors of outcome in advanced colorectal cancer (ACRC) is poorly understood. We examined these factors as predictors of treatment toxicity and outcome in cetuximab-treated patients with ACRC. PATIENTS AND METHODS: comorbidity was independently evaluated using the Charlson Comorbidity Index (CCI), a validated measure of comorbidity based on the presence of medical conditions weighted according to their effect on mortality. CCI score was correlated with clinical and outcome data. RESULTS: five hundred and seventy-two patients were included; 41% were ≥ 65 years and 25% had comorbidities at randomization. In multivariate analysis (MVA) of all covariates, only older age was associated with greater comorbidity (P = 0.008). Overall survival (OS) was significantly better for patients with greater comorbidity in univariate analysis (P = 0.047). Conversely, better PS was associated with better OS in MVA (hazard ratio 1.92 for PS = 2 versus PS = 0, P < 0.0001). Age was not associated with OS (P = 0.13). Elderly patients had significantly less grade ≥ 3 vomiting (P = 0.034) but more dyspnea (P = 0.005). Patients with greater comorbidity had significantly less grade ≥ 3 vomiting (P = 0.002) but more non-neutropenic fever (P = 0.005). CONCLUSION: better PS was associated with improved OS. For patients with good PS, restricting cetuximab use in the setting of significant comorbidity does not appear justified.


Assuntos
Anticorpos Monoclonais/uso terapêutico , Antineoplásicos/uso terapêutico , Neoplasias Colorretais/tratamento farmacológico , Neoplasias Colorretais/terapia , Cuidados Paliativos/métodos , Fatores Etários , Idoso , Anticorpos Monoclonais/efeitos adversos , Anticorpos Monoclonais Humanizados , Antineoplásicos/efeitos adversos , Cetuximab , Comorbidade , Intervalo Livre de Doença , Feminino , Humanos , Masculino , Análise Multivariada , Fatores de Risco , Taxa de Sobrevida
2.
J Chemother ; 32(3): 151-155, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32124685

RESUMO

Staphylococcus pseudintermedius is a well known commensal organism of dogs but also a canine opportunistic pathogen. Reports of this organism being recovered from specimens from humans might suggest an increase prevalence in human infections and/or improved diagnostic leading to more accurate identification. Here we report a case of persistent S. pseudintermedius infection in an adult female oncology patient including colonization of the tip of an indwelling catheter. Diligence by laboratories in correctly isolating and identifying this pathogen (including susceptibility testing) is essential for optimal patient care.


Assuntos
Antineoplásicos/uso terapêutico , Zoonoses Bacterianas/diagnóstico , Neoplasias Retais/tratamento farmacológico , Infecções Estafilocócicas/diagnóstico , Staphylococcus , Animais , Zoonoses Bacterianas/transmissão , Cateteres de Demora/microbiologia , Cães , Feminino , Humanos , Pessoa de Meia-Idade , Metástase Neoplásica , Animais de Estimação , Infecções Estafilocócicas/transmissão
3.
Colorectal Dis ; 11(2): 198-202, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18462249

RESUMO

AIM: Antecedent attacks of diverticulitis are thought to increase the risk of complicated diverticulitis, and unless elective surgery is performed, a high proportion of patients with recurrent symptoms will require emergency operations for complicated diverticulitis with its associated morbidity. In this multicentre study, we aim to assess impact of previous attacks of diverticulitis on patients requiring an emergency surgical intervention. METHOD: All patients operated on as an emergency for complicated diverticulitis were retrospectively analysed. Patients were separated into two groups: group A included patients without previous history of diverticular disease, and group B those with previous attacks of diverticulitis. RESULTS: A total of 96 patients were included in the study. Group A included 68 (70.8%) patients, and group B 28 (29.2%) patients. Generalized peritonitis was the reason for operation in 50 (73.5%) patients in-group A and only four (14%) patients in group B. Perforated diverticulitis occurred more often in group A, whereas pericolonic abscess and phlegmon formation occurred more commonly in group B. Resection was performed in all patients in group B; 50% had a Hartmann's procedure, and the other 50% patients had primary anastomosis. Hartmann's procedure was performed in 52 patients (76.5%) in group A, and 8 patients (11.7%) had resection and primary anastomosis. No difference in postoperative complications was identified between the groups. CONCLUSION: Multiple attacks of diverticulitis are not associated with an increased risk of complicated diverticulitis. Recurrent episodes of diverticulitis are not associated with a less favourable outcome or an increased risk of fatality if complications ensue.


Assuntos
Doença Diverticular do Colo/cirurgia , Perfuração Intestinal/cirurgia , Doença Aguda , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Colectomia/mortalidade , Doença Diverticular do Colo/mortalidade , Emergências , Feminino , Humanos , Incidência , Perfuração Intestinal/mortalidade , Israel/epidemiologia , Masculino , Pessoa de Meia-Idade , Recidiva
4.
Hautarzt ; 53(2): 114-7, 2002 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-11963190

RESUMO

Ulcerated primary cutaneous lymphomas are not rare, but the clinical manifestation as a pyoderma gangrenosum look-alike is extraordinary. CD8-positive lymphomas are rare, unclassifiable tumours with variable prognosis. We report on a 49-year-old patient with a large ulcerated primary cutaneous lymphoma on the left chest wall presenting as pyoderma gangrenosum. With immunohistochemical staining, most lymphocytes were shown to be CD8-positive. The CD30 antigen was not expressed. After radiotherapy with complete skin irradiation, the lymphoma regressed completely. The patient has been free of relapse for 28 months so far.


Assuntos
Antígenos CD8/análise , Antígeno Ki-1/análise , Linfoma Cutâneo de Células T/diagnóstico , Pioderma Gangrenoso/diagnóstico , Neoplasias Cutâneas/diagnóstico , Diagnóstico Diferencial , Humanos , Linfócitos/patologia , Linfoma Cutâneo de Células T/patologia , Linfoma Cutâneo de Células T/radioterapia , Masculino , Pessoa de Meia-Idade , Pioderma Gangrenoso/patologia , Pele/patologia , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/radioterapia
5.
Mol Cell Biochem ; 162(2): 97-103, 1996 Sep 20.
Artigo em Inglês | MEDLINE | ID: mdl-8905631

RESUMO

Colorectal cancer has a high incidence of morbidity and mortality in the North American population. Elevated levels of plasmalogens have been reported in some neoplastic tissues including colon tumors, but the mechanism for this increase has not been defined. Since changes in plasmalogen level are usually associated with changes in the other phospholipid subclasses, a general increase in all phospholipid subclasses may also be found in colonic neoplasms. In this study, the levels of the major phospholipids, including their plasmalogen and diacylphospholipid subclasses, were found to be elevated in human malignant colonic tissues. Since phosphatidylcholine is the most prominent type of phospholipid found in both malignant and control tissues, the mechanism for its accumulation during malignancy was investigated. Decreases in phospholipase C and D activities were observed in tumor samples, but an enhancement of the CTP: phosphocholine cytidylyltransferase activity was also detected. Immunoblotting analysis revealed that the elevated cytidylyltransferase activity was caused by a three-fold increase in the level of enzyme protein during tumor development. Based on these enzyme studies, we conclude that the high level of phosphatidylcholine in colon tumors resulted from a decrease in its turnover and an increase in its expression.


Assuntos
Neoplasias do Colo/metabolismo , Fosfatidilcolinas/metabolismo , Colo/enzimologia , Colo/metabolismo , Colo/patologia , Neoplasias do Colo/enzimologia , Neoplasias do Colo/patologia , Humanos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patologia , Nucleotidiltransferases/metabolismo , Fosfolipídeos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA